Spirolactone for inhibiting the cardiotoxic effects of adriamycin
US4003996A · kind A · utility
8Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 9, 1974 |
| Grant date | Jan 18, 1977 |
| Priority date | — |
| Expiry date | Sep 9, 1994 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/585
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The administration of aldosterone inhibitors of the spirolactone structural type prior to and during treatment with anti-neoplastic agents such as adriamycin results in retention of the desired activity of the latter substances while inhibiting their undesirable cardiotoxic properties.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.